Friday, 14 December 2018
Latest news
Main » Analysts Estimates And Ratings Exact Sciences Corporation (EXAS)

Analysts Estimates And Ratings Exact Sciences Corporation (EXAS)

09 March 2018

The company reported the earnings of $-0.18/Share in the last quarter where the estimated EPS by analysts was $-0.24/share. Schmidt P J Investment Management Inc who had been investing in Yum Brands Inc for a number of months, seems to be less bullish one the $27.07 billion market cap company. The lowest price the stock reached in the last trading day was $0.65 and compares with the $0.45 52-week low. About 154,215 shares traded or 66.68% up from the average. BCB Bancorp, Inc. (NASDAQ:BCBP) has risen 53.81% since March 9, 2017 and is uptrending. It has outperformed by 7.33% the S&P500.

Nicholas Investment Partners Lp increased its stake in Exact Sciences Corp (EXAS) by 63.89% based on its latest 2017Q3 regulatory filing with the SEC. The institutional investor held 36,600 shares of the commercial physical & biological resarch company at the end of 2017Q3, valued at $1.73M, up from 27,500 at the end of the previous reported quarter. State of Wisconsin Investment Board now owns 107,253 shares of the medical research company's stock valued at $5,054,000 after buying an additional 22,253 shares during the last quarter. In the last ninety days, insiders sold 547,463 shares of company stock valued at $27,045,199. The stock traded with the average Volume of 2.77 Million at the end of last session.

Exact Sciences Corporation (EXAS) shares jumped 3.04 percent and closed the day at $49.21. It has outperformed by 441.54% the S&P500.

Analysts await Anthem, Inc. (NYSE:YUM) to report earnings on May, 2. Blackrock Incorporated reported 7.53M shares stake. The insider COWARD D SCOTT sold $1.37M. 150.22 million shares or 5.13% less from 158.35 million shares in 2017Q2 were reported. The firm earned "Buy" rating on Thursday, October 19 by Bank of America. The firm has "Hold" rating given on Friday, September 23 by Evercore. As per Thursday, October 1, the company rating was initiated by Craig Hallum. The stock of YUM! (NYSE:ANTM) has "Buy" rating given on Wednesday, September 20 by Cowen & Co. (NYSE:ANTM) earned "Buy" rating by Cleveland on Friday, April 8. Brands, Inc. (NYSE:YUM) has "Underperform" rating given on Thursday, July 14 by CLSA. HSBC upgraded the shares of PHI in report on Friday, October 14 to "Buy" rating. Credit Suisse downgraded PLDT Inc. (NYSE:ANTM) rating on Friday, October 13. Its up 0.22, from 0.77 in 2017Q2. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 10.80% with $117.18 Million sitting short, betting on future declines. Fmr Limited Liability Corporation holds 0.01% or 2.45 million shares. Eqis Cap Mngmt accumulated 0.01% or 4,647 shares. Sanctuary Wealth Limited Liability Corp holds 3.18% or 87,180 shares. Sei has 43,566 shares for 0.01% of their portfolio. First Manhattan, New York-based fund reported 430,710 shares. Grs Advsr Limited Company reported 6.98% of its portfolio in Hudson Pacific Properties, Inc. (NYSE:HPP). Commonwealth Bancorp Of Australia accumulated 0.43% or 1.33M shares. Ahl Prtnrs Llp holds 0.07% or 54,585 shares. Brands, Inc. (NYSE:YUM). New Mexico-based New Mexico Educational Retirement Board has invested 0.11% in YUM!

Clearline Capital Lp, which manages about $865.30M and $137.36 million US Long portfolio, upped its stake in Inc Resh Hldgs Inc (NASDAQ:INCR) by 29,439 shares to 162,508 shares, valued at $8.50 million in 2017Q3, according to the filing. Linscomb & Williams holds 0.07% or 11,114 shares in its portfolio. Kornitzer Cap Management Ks owns 284,340 shares or 0.23% of their USA portfolio. Alexandria Cap Ltd Liability Corp holds 600 shares. LLC now owns 2,356,706 shares of the medical research company's stock worth $83,357,000 after purchasing an additional 875,527 shares in the last quarter. Therefore 56% are positive.

EXACT Sciences Co. has a fifty-two week low of $19.91 and a fifty-two week high of $63.60. The stock has "Equal-Weight" rating by Stephens on Thursday, February 25. The firm has "Buy" rating given on Tuesday, July 4 by Jefferies. Topeka Capital Markets maintained the stock with "Hold" rating in Monday, November 30 report. (NASDAQ:EXAS) opened at $47.76 on Wednesday. The stock has "Neutral" rating by Mizuho on Wednesday, May 4. The firm has "Buy" rating given on Wednesday, June 7 by Canaccord Genuity. Benchmark lowered shares of EXACT Sciences from a "buy" rating to a "hold" rating in a research note on Friday, February 23rd.

Investors sentiment decreased to 0.88 in Q3 2017. Its up 0.13, from 1.11 in 2017Q2. It is negative, as 39 investors sold EXAS shares while 81 reduced holdings.

A number of hedge funds have recently added to or reduced their stakes in the stock. The firm's revenue was up 148.0% compared to the same quarter last year. analysts expect that EXACT Sciences Co. will post -0.84 EPS for the current fiscal year. LIDGARD GRAHAM PETER also sold $1.50M worth of Exact Sciences Corporation (NASDAQ:EXAS) on Monday, February 26. (NASDAQ:EXAS) by 39.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. Victory Capital Management Inc. boosted its stake in EXACT Sciences by 82.9% in the 4th quarter. Metropolitan Life Insur reported 78,177 shares or 0.02% of all its holdings. Perhaps, that suggests something about why 3.13% of the outstanding share supply is held by institutional investors.

Biondo Investment Advisors Llc increased its stake in Exact Sciences Corp (EXAS) by 33.09% based on its latest 2017Q3 regulatory filing with the SEC. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/03/08/exact-sciences-co-exas-short-interest-update.html. LLC raised its holdings in shares of EXACT Sciences by 163.0% in the 3rd quarter.

Since September 29, 2017, it had 0 insider buys, and 14 sales for $27.28 million activity. 2,982 shares were sold by Elliott Jeffrey Thomas, worth $126,252.

The company's Average Revenue Estimate for the current quarter is $86.93 Million, while Low and High Revenue Estimates are $84.6 Million and $93.92 Million respectively.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.